PLSCR1 is a cell-autonomous defence factor against SARS-CoV-2 infection

Understanding protective immunity to COVID-19 facilitates preparedness for future pandemics and combats new SARS-CoV-2 variants emerging in the human population. Neutralizing antibodies have been widely studied; however, on the basis of large-scale exome sequencing of protected versus severely ill p...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Dijin, Jiang, Weiqian, Wu, Lizhen, Gaudet, Ryan G., Park, Eui-Soon, Su, Maohan, Cheppali, Sudheer Kumar, Cheemarla, Nagarjuna R., Kumar, Pradeep, Uchil, Pradeep D., Grover, Jonathan R., Foxman, Ellen F., Brown, Chelsea M., Stansfeld, Phillip J., Bewersdorf, Joerg, Mothes, Walther, Karatekin, Erdem, Wilen, Craig B., MacMicking, John D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10371867/
https://www.ncbi.nlm.nih.gov/pubmed/37438530
http://dx.doi.org/10.1038/s41586-023-06322-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10371867/
https://www.ncbi.nlm.nih.gov/pubmed/37438530
http://dx.doi.org/10.1038/s41586-023-06322-y

Ejemplares similares